SmartPill公司研发出诊断胃轻瘫综合征的可吞服胶囊

 
一种无线可吞服的医疗设备，体积如同一个较大的维生素丸，有助于胃排空减缓的鉴别，或者叫做胃轻瘫综合征，多年来一直未能作出全面性诊断。胃轻瘫综合征能够影响许多患者，包括大约50％的糖尿病和帕金森病患者。

SmartPill胃肠道(GI)监测系统是由SmartPill公司(Buffalo, NY, USA)研发的，已经获得了美国食品药品管理局(FDA)的许可，给予该公司在美国销售使用该套系统和SmartPill pH.p胶囊的授权。
 
Ingestible Capsule Evaluates Patients for Gastroparesis
 
A wireless, ingestible medical device, about the size of a large vitamin pill, will aid in the identification of slow gastric emptying, or gastroparesis, which has been underdiagnosed in patients for years. Gastroparesis is a condition that affects a wide range of patients, including up to an estimated 50% of diabetics and those suffering from Parkinson’s disease.

The SmartPill gastrointestinal (GI) monitoring system developed by SmartPill Corp. (Buffalo, NY, USA) has been cleared by the U.S. Food and Drug Administration (FDA), granting the company authorization for the sale and use of the system and the SmartPill pH.p capsule in the United States.